Literature DB >> 27881396

Involvement of infiltrating macrophage-derived activin A in the progression of renal damage in MRL-lpr mice.

Anastasie Tshilela Kadiombo1, Akito Maeshima2, Ken Kayakabe1, Hidekazu Ikeuchi1, Toru Sakairi1, Yoriaki Kaneko1, Keiju Hiromura1, Yoshihisa Nojima1.   

Abstract

Lupus nephritis is a life-threatening complication of systemic lupus erythematosus (SLE). Various growth factors, cytokines, and chemokines are implicated in the development of SLE. However, the pathophysiological processes involved in the development of lupus nephritis still remain unclear. In this study, we examined the involvement of activin A, a member of the transforming growth factor β (TGF-β) superfamily, in the progression of renal damage in lupus-prone MRL-lpr mice. Activin A was not expressed in the kidneys of control MRL-MpJ mice but was detectable in perivascular infiltrating cluster of differentiation 68 (CD68)-positive cells in the kidneys of MRL-lpr mice. Urinary activin A, which was also absent in MRL-MpJ mice, was detectable in MRL-lpr mice from 16 wk onward. Urinary activin A levels were significantly correlated with the number of perivascular inflammatory cell layers, the number of crescentic glomeruli, and the percentage of Elastica van Gieson (EVG)-positive fibrotic areas, but not with urinary protein levels or serum activin A. When activin action was blocked in vivo by the intraperitoneal administration of an activin antagonist, follistatin, the number of crescentic glomeruli, percentage of EVG-positive fibrotic areas, CD68-positive cell infiltration, and proteinuria were significantly reduced in a dose-dependent manner. These data suggest that infiltrating macrophage-derived activin A is involved in the progression of renal damage in MRL-lpr mice.
Copyright © 2017 the American Physiological Society.

Entities:  

Keywords:  activin; lupus nephritis; urinary biomarker

Mesh:

Substances:

Year:  2016        PMID: 27881396     DOI: 10.1152/ajprenal.00191.2016

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  6 in total

Review 1.  Renal Macrophages and Dendritic Cells in SLE Nephritis.

Authors:  Naomi I Maria; Anne Davidson
Journal:  Curr Rheumatol Rep       Date:  2017-11-09       Impact factor: 4.592

2.  Circadian rhythm of activin A and related parameters of mineral metabolism in normal and uremic rats.

Authors:  Anders Nordholm; Søren Egstrand; Eva Gravesen; Maria L Mace; Marya Morevati; Klaus Olgaard; Ewa Lewin
Journal:  Pflugers Arch       Date:  2019-06-24       Impact factor: 3.657

3.  Urinary Activin A is a novel biomarker reflecting renal inflammation and tubular damage in ANCA-associated vasculitis.

Authors:  Yoshinori Takei; Shunsuke Takahashi; Masao Nakasatomi; Toru Sakairi; Hidekazu Ikeuchi; Yoriaki Kaneko; Keiju Hiromura; Yoshihisa Nojima; Akito Maeshima
Journal:  PLoS One       Date:  2019-10-15       Impact factor: 3.240

4.  Identification of Urinary Activin A as a Novel Biomarker Reflecting the Severity of Acute Kidney Injury.

Authors:  Shunsuke Takahashi; Masao Nakasatomi; Yoshinori Takei; Hidekazu Ikeuchi; Toru Sakairi; Yoriaki Kaneko; Keiju Hiromura; Yoshihisa Nojima; Akito Maeshima
Journal:  Sci Rep       Date:  2018-03-26       Impact factor: 4.379

5.  Androgen-Influenced Polarization of Activin A-Producing Macrophages Accompanies Post-pyelonephritic Renal Scarring.

Authors:  Teri N Hreha; Christina A Collins; Allyssa L Daugherty; Jessie M Griffith; Keith A Hruska; David A Hunstad
Journal:  Front Immunol       Date:  2020-07-28       Impact factor: 7.561

6.  Senescence marker activin A is increased in human diabetic kidney disease: association with kidney function and potential implications for therapy.

Authors:  Xiaohui Bian; Tomás P Griffin; Xiangyang Zhu; Md Nahidul Islam; Sabena M Conley; Alfonso Eirin; Hui Tang; Paula M O'Shea; Allyson K Palmer; Rozalina G McCoy; Sandra M Herrmann; Ramila A Mehta; John R Woollard; Andrew D Rule; James L Kirkland; Tamar Tchkonia; Stephen C Textor; Matthew D Griffin; Lilach O Lerman; LaTonya J Hickson
Journal:  BMJ Open Diabetes Res Care       Date:  2019-12-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.